|
Real-time
OTC Markets
18:25:24 01/09/2021 +04
|
5-day change | 1st Jan Change | ||
| 0.5000 USD | +66.67% |
|
+166,566.67% | +166,566.67% |
| 29/11/17 | Optigenex Inc. announced that it has received $0.63 million in funding | CI |
| 07/11/17 | Optigenex Inc. announced a financing transaction | CI |
| Market Cap | 19.94K 17.36K 16.43K 14.93K 27.89K 1.91M 28.03K 196K 75.69K 970K 74.89K 73.22K 3.11M | P/E 2006 * |
-
| P/E 2007 | - |
|---|---|---|---|---|---|
| Enterprise Value | 8.95M 7.8M 7.38M 6.71M 12.53M 858M 12.59M 87.92M 33.99M 436M 33.64M 32.89M 1.4B | EV / Sales 2006 |
20.5x | EV / Sales 2007 | 19.3x |
| Free-Float |
21.27% | Yield 2006 * |
-
| Yield 2007 | - |
| 1 day | +66.67% | ||
| 1 week | +166,566.67% | ||
| Current month | +166,566.67% | ||
| 1 month | +166,566.67% | ||
| 3 months | +166,566.67% | ||
| 6 months | +166,566.67% | ||
| Current year | +166,566.67% |
| Current year | 0 | 0.5 | |
| 1 year | 0 | 0.5 | |
| 3 years | 0 | 0.5 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 69 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +66.67% | +166,566.67% | +1,140.69% | -50.00% | 35 | ||
| +0.67% | +2.04% | +50.75% | +100.58% | 1,014B | ||
| +0.49% | +0.71% | +51.38% | +65.10% | 644B | ||
| -0.03% | +2.88% | +18.81% | +70.42% | 464B | ||
| -0.36% | +4.54% | +38.71% | +40.03% | 354B | ||
| +1.52% | +3.46% | +20.13% | +26.08% | 265B | ||
| +2.41% | +5.70% | +9.06% | +15.85% | 253B | ||
| +0.77% | -0.82% | +38.09% | +44.16% | 203B | ||
| +2.48% | -2.43% | -24.40% | -57.05% | 186B | ||
| +1.21% | +3.29% | +33.24% | +97.80% | 183B | ||
| Average | +7.58% | +0.86% | +137.65% | +35.30% | 356.68B | |
| Weighted average by Cap. | +0.76% | +1.41% | +34.74% | +61.11% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 301K 262K 248K 225K 421K 28.82M 423K 2.95M 1.14M 14.65M 1.13M 1.11M 46.89M | 466K 406K 384K 349K 652K 44.63M 655K 4.58M 1.77M 22.68M 1.75M 1.71M 72.6M |
| Net income | -7.36M -6.41M -6.07M -5.51M -10.29M -705M -10.35M -72.24M -27.93M -358M -27.64M -27.02M -1.15B | -2.9M -2.52M -2.39M -2.17M -4.05M -278M -4.07M -28.45M -11M -141M -10.89M -10.64M -451M |
| Net Debt | 6M 5.23M 4.95M 4.49M 8.39M 575M 8.44M 58.9M 22.78M 292M 22.54M 22.03M 935M | 8.93M 7.78M 7.36M 6.69M 12.5M 856M 12.56M 87.72M 33.92M 435M 33.56M 32.81M 1.39B |
Employees
1
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OPGX Stock
Select your edition
All financial news and data tailored to specific country editions
















